Prospective study for evaluating the safety of LECS as the option treatment for elderly gastric cancer

Prospective study for evaluating the safety of LECS as the option treatment for elderly gastric cancer - A prospective study of the LECS for elderly gastric cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039807

Enrollment

Registered

2020-03-13

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

LECS

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Histologically proven gastric cancer 2) Preoperatively diagnosed as "advanced gastric cancer within 5cm" or "early gastric cancer with relative indication according to guideline or early gastric cancer indicative of ESD treatment, but technically difficult for ESD" 3) Neither Borrmann type 4 nor large (>=8 cm) type 3 4) Patient who can do oral intake 5) With written informed consent before surgery

Exclusion criteria

Exclusion criteria: 1) Patients who can not be applied general aneshtesia 2) Patients without preoperative informed consent

Design outcomes

Primary

Measure	Time frame
Incidence rate of postoperative complications (Clavien Dindo III or above)	—

Secondary

Measure	Time frame
Overall survival (OS), Disease specific survival (DSS), Blood loss, Operation time, Postoperative hospital stay, Lean body mass, QOL	—

Countries

Japan

Contacts

Public ContactEthics Examination Office Kitasato University Hospital

Kitasato University Hospital Ethics Examination Office

rinrib@med.kitasato-u.ac.jp042-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026